These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23350859)

  • 1. Factors influencing time to diagnosis after abnormal mammography in diverse women.
    Pérez-Stable EJ; Afable-Munsuz A; Kaplan CP; Pace L; Samayoa C; Somkin C; Nickleach D; Lee M; Márquez-Magaña L; Juarbe T; Pasick RJ
    J Womens Health (Larchmt); 2013 Feb; 22(2):159-66. PubMed ID: 23350859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing reminder and motivational telephone calls to increase screening mammography: a randomized study.
    Taplin SH; Barlow WE; Ludman E; MacLehos R; Meyer DM; Seger D; Herta D; Chin C; Curry S
    J Natl Cancer Inst; 2000 Feb; 92(3):233-42. PubMed ID: 10655440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are risk factors for breast cancer associated with follow-up procedures in diverse women with abnormal mammography?
    Juarbe TC; Kaplan CP; Somkin CP; Pasick R; Gildengorin G; Pérez-Stable EJ
    Cancer Causes Control; 2005 Apr; 16(3):245-53. PubMed ID: 15947876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timeliness of abnormal screening and diagnostic mammography follow-up at facilities serving vulnerable women.
    Goldman LE; Walker R; Hubbard R; Kerlikowske K;
    Med Care; 2013 Apr; 51(4):307-14. PubMed ID: 23358386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in abnormal mammogram follow-up time for Asian women compared with non-Hispanic white women and between Asian ethnic groups.
    Nguyen KH; Pasick RJ; Stewart SL; Kerlikowske K; Karliner LS
    Cancer; 2017 Sep; 123(18):3468-3475. PubMed ID: 28603859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of false-positive mammograms on interval breast cancer screening in a health maintenance organization.
    Burman ML; Taplin SH; Herta DF; Elmore JG
    Ann Intern Med; 1999 Jul; 131(1):1-6. PubMed ID: 10391809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial and geographic differences in mammography screening in St. Louis City: a multilevel study.
    Lian M; Jeffe DB; Schootman M
    J Urban Health; 2008 Sep; 85(5):677-92. PubMed ID: 18622709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of follow-up after abnormal screening and diagnostic mammograms.
    Wernli KJ; Aiello Bowles EJ; Haneuse S; Elmore JG; Buist DS
    Am J Manag Care; 2011 Feb; 17(2):162-7. PubMed ID: 21473665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammography facilities serving vulnerable women have longer follow-up times.
    Karliner LS; Kaplan C; Livaudais-Toman J; Kerlikowske K
    Health Serv Res; 2019 Feb; 54 Suppl 1(Suppl 1):226-233. PubMed ID: 30394526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Language barriers, location of care, and delays in follow-up of abnormal mammograms.
    Karliner LS; Ma L; Hofmann M; Kerlikowske K
    Med Care; 2012 Feb; 50(2):171-8. PubMed ID: 21993060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammography performance in Oman: Review of factors influencing cancer yield and positive predictive value.
    Taif S; Tufail F; Alnuaimi AS
    Asia Pac J Clin Oncol; 2016 Jun; 12(2):e250-8. PubMed ID: 24673798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible logistic and sociodemographyc factors on breast cancer screening in Turkey: lessons from a women’s health project in Mersin province.
    Abali H; Ata A; Gokçe G; Gokçe H
    J Cancer Educ; 2012 Jun; 27(2):347-52. PubMed ID: 21976034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms.
    McCarthy AM; Keller B; Kontos D; Boghossian L; McGuire E; Bristol M; Chen J; Domchek S; Armstrong K
    Breast Cancer Res; 2015 Jan; 17(1):1. PubMed ID: 25567532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cancer-screening tests in the San Francisco Bay area: comparison of Latinos and Anglos.
    Pérez-Stable EJ; Sabogal F; Otero-Sabogal R
    J Natl Cancer Inst Monogr; 1995; (18):147-53. PubMed ID: 8562215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. U.S. women's perceived importance of the harms and benefits of mammograms and associations with screening ambivalence: Results from a national survey.
    Qin X; Nagler RH; Fowler EF; Gollust SE
    Prev Med; 2019 Jun; 123():130-137. PubMed ID: 30890352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreasing women's anxieties after abnormal mammograms: a controlled trial.
    Barton MB; Morley DS; Moore S; Allen JD; Kleinman KP; Emmons KM; Fletcher SW
    J Natl Cancer Inst; 2004 Apr; 96(7):529-38. PubMed ID: 15069115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to mammography screening among racial and ethnic minority women.
    Miller BC; Bowers JM; Payne JB; Moyer A
    Soc Sci Med; 2019 Oct; 239():112494. PubMed ID: 31513931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes of Colorado health professionals toward breast and cervical cancer screening in Hispanic women.
    Bakemeier RF; Krebs LU; Murphy JR; Shen Z; Ryals T
    J Natl Cancer Inst Monogr; 1995; (18):95-100. PubMed ID: 8562228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a U.S. National Survey.
    Yabroff KR; Breen N; Vernon SW; Meissner HI; Freedman AN; Ballard-Barbash R
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):723-32. PubMed ID: 15159302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing mammography utilization: a controlled study.
    Fletcher SW; Harris RP; Gonzalez JJ; Degnan D; Lannin DR; Strecher VJ; Pilgrim C; Quade D; Earp JA; Clark RL
    J Natl Cancer Inst; 1993 Jan; 85(2):112-20. PubMed ID: 8418300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.